NCT03802149View on ClinicalTrials.gov

Ulipristal Acetate for Cervical Preparation

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

April 16, 2019

Primary Completion Date

April 2, 2020

Study Completion Date

April 2, 2020

Conditions
Termination of Pregnancy
Interventions
DRUG

Ulipristal Acetate

90mg Ulipristal Acetate 18-24-hours prior to dilation and evacuation

Trial Locations (1)

94305

Stanford Health Care, Stanford

All Listed Sponsors
lead

Stanford University

OTHER

NCT03802149 - Ulipristal Acetate for Cervical Preparation | Biotech Hunter | Biotech Hunter